Part of the Stock Digest group of websites: Visit Small Cap Stock Digest  

Medical Cannabis Market Expected to Grow Rapidly Over Next Four Years, Report Says

A new market report has indicated the medical cannabis industry is set to see remarkable growth over the next four years.

The report, issued by Technavio, a technology research and advisory company, indicates the medical marijuana market will see a compound annual growth rate (CAGR) of 21 percent between 2018 until 2022.

“The increasing use of cannabis for medical purposes is a major factor driving the market’s growth,” Technavio said in its announcement.

When it comes to the expansion of cannabis for medical purposes, the main market driving this growth will be North America, according to the report.

“Owing to the growing consumption of medical marijuana, the region will offer the maximum growth opportunities to the companies in this medical marijuana market during the next four years,” the abstract for the report said.

Recognition for the potential of the medical cannabis market

In an interview with the Investing News Network (INN) Neil Closner, CEO of MedReleaf (TSX:LEAF) confirmed he views the international medical cannabis market as the largest option available for companies in the space.

If you look to countries that are moving towards [legalization of medical cannabis,] many of them are larger than Canada is and many of them will have full government covered cannabis for medical purposes,” Closner said.

He offered Germany as an example of a country with a population of  80 million with full insurance coverage.

Click here to continue reading...

Subscribe to the SCSD email list and get the latest small cap stock activity directly to your inbox, for free.



Name Last Change
DOW 23675.60 0.35%
S&P 500 2546.16 0.01%
NASDAQ 6783.91 0.44%
TSX 14416.89 0.38%
TSX-V 543.19 0.00%
RTY 1377.18 0.07%


Name Last Change
APPL 166.07 1.28%
GOOG 1028.71 1.18%

@SmallCapDigest ON TWITTER

Part of the Stock Digest family of websites
Resource Stock Digest